Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
biotech
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
deals
ipo
medicare
startups
aducanumab
aduro biotech
biomarin pharmaceutical
cancer immunotherapy
celgene
What
bio
roundup
companies
drug
gene
new
price
talk
activity
alzheimer’s
approval
approvals
becker
billions
biogen
biogen’s
biopharmaceutical
clamped
convo
covid
delays
developing
different
dollars
earlier
eaton
economic
fail
failures
fast
fda
healthcare
impact
including
increases
ipo
isn’t
latest
life
littered
Language
unset
Current search:
novartis
×
biogen
×
" seattle blog main "
×
cancer
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More